CENTRAL NERVOUS SYSTEM FUNCTIONAL ANATOMY STUDIES
中枢神经系统功能解剖学研究
基本信息
- 批准号:3759386
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer's disease Huntington's disease antidepressants arousal autoradiography basal ganglia brain mapping cannabinoids cocaine corticotropin releasing factor drug addiction drug receptors electroconvulsive therapy human tissue in situ hybridization laboratory rat locus coeruleus mood disorders neuroendocrine system neuropeptides neurotransmitter receptor psychosis stress
项目摘要
The Section on Functional Neuroanatomy combines molecular and
neuroanatomical methods to characterize and localize dynamic CNS events
that relate to issues of mental health and drug abuse. Mapping drug and
neurotransmitter receptors using in vitro ligand binding and
autoradiography has provided important basic information about brain
organization and function. In situ hybridization histochemistry is used
to localize and quantify mRNA expression of neuropeptides, monoamine
transporters and synthesizing enzymes, adrenal steroid receptors and
immediate-early genes in studies of adaptive changes to behavioral,
pharmacological, or surgical interventions. (l) The cannabinoid
receptor has been localized to specific neuronal elements in brain, and
we showed its down regulation in rats after repeated delta-9-
tetrahydrocannabinol (THC) administration, which produces behavioral
tolerance. 2) In brains of human cocaine addicts, we showed molecular
alterations in the basal ganglia caused by chronic cocaine use in an
attempt to understand the neurochemical basis of craving and addiction.
3) Studies based on animal models of depression are designed to
elucidate brain mechanisms involved in the therapeutic amelioration of
chronic stress. Treatments such as antidepressant drug administration
and electroconvulsive shock are used in conjunction with acute and
chronic stress. Brain systems responsive to both stress and therapeutic
treatment include the corticotropin-releasing hormone. (CRH) component
of the hypothalamic paraventricular nucleus, which controls the
hypothalamic-pituitary-adrenal axis and the noradrenergic locus
coeruleus, which plays a crucial role in arousal and vigilance.
功能神经解剖学部分结合了分子和
描述和定位动态CNS事件的神经解剖学方法
与精神健康和药物滥用有关的问题。映射药物和
使用体外配体结合的神经递质受体和
放射自显影术提供了有关脑的重要基础信息
组织和功能。采用原位杂交组织化学方法
定位和定量神经肽,单胺,
转运蛋白和合成酶,肾上腺类固醇受体,
在行为适应性变化的研究中,
药物或手术干预。(l)大麻素
受体定位于大脑中特定的神经元元件,
我们在大鼠中发现了它的下调,
四氢大麻酚(THC)给药,其产生行为
宽容2)在可卡因成瘾者的大脑中,我们发现
慢性可卡因使用引起的基底神经节的改变,
试图理解渴望和成瘾的神经化学基础。
3)基于抑郁症动物模型的研究旨在
阐明参与治疗改善的脑机制
慢性压力抗抑郁药物等治疗
和电休克是用来与急性和
慢性压力大脑系统对压力和治疗都有反应
治疗包括促肾上腺皮质激素释放激素。(CRH)组件
下丘脑室旁核,它控制着
下丘脑-垂体-肾上腺轴和去甲肾上腺素能位点
蓝斑,在唤醒和警惕中起着至关重要的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M HERKENHAM其他文献
M HERKENHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M HERKENHAM', 18)}}的其他基金
相似海外基金
Exploring the role of epigenetic mechanisms in the manifestation of Huntington's disease
探索表观遗传机制在亨廷顿舞蹈病表现中的作用
- 批准号:
MR/Y014685/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Project 3: Therapeutic Gene Editing for Huntington's Disease
项目3:亨廷顿病的治疗性基因编辑
- 批准号:
10668769 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Brain-targeted delivery of therapeutic molecules by exosomes derived from engineered human iPS cells: a potential therapeutic approach for Huntington's disease
通过源自工程化人类 iPS 细胞的外泌体向大脑靶向递送治疗分子:亨廷顿病的潜在治疗方法
- 批准号:
10588392 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Emerging role of glymphatic clearance in Huntington's disease
类淋巴清除在亨廷顿病中的新作用
- 批准号:
10599627 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Characterizing GABAergic transmission at the cellular and synaptic levels in the developing and mature basal ganglia of the Huntington's Disease brain
描述亨廷顿病大脑发育和成熟基底神经节细胞和突触水平上的 GABA 能传递
- 批准号:
478477 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Operating Grants
Using genetic modifiers to identify and target pathogenic mechanisms in Huntington's disease
使用遗传修饰剂来识别和靶向亨廷顿病的致病机制
- 批准号:
MR/X018253/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fellowship
Repeat-induced mutagenesis in Huntington's disease
亨廷顿病的重复诱导突变
- 批准号:
MR/X02184X/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant
Elucidating Semaphorin-6D Signaling Axis in Huntington's Disease
阐明亨廷顿病中的 Semaphorin-6D 信号轴
- 批准号:
23K14503 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Modulation of Somatic Repeat Expansion as a Therapeutic Approach to Huntington's Disease
调节体细胞重复扩增作为亨廷顿病的治疗方法
- 批准号:
10678016 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identifying New Astrocytic Kir4.1 Channel Modulators for Treating Huntington's Disease
鉴定用于治疗亨廷顿病的新型星形细胞 Kir4.1 通道调节剂
- 批准号:
10681097 - 财政年份:2023
- 资助金额:
-- - 项目类别: